Menu
Back to Journals » Drug Design, Development and Therapy » Volume 7
Animal models of ulcerative colitis and their application in drug research
Authors Low D, Nguyen DD, Mizoguchi E
Received 23 August 2013
Accepted for publication 3 October 2013
Published 12 November 2013 Volume 2013:7 Pages 1341—1357
DOI https://doi.org/10.2147/DDDT.S40107
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Daren Low,1 Deanna D Nguyen,1,2 Emiko Mizoguchi1,2
1Gastrointestinal Unit, Department of Medicine, 2Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Abstract: The specific pathogenesis underlying inflammatory bowel disease is complex, and it is even more difficult to decipher the pathophysiology to explain for the similarities and differences between two of its major subtypes, Crohn's disease and ulcerative colitis (UC). Animal models are indispensable to pry into mechanistic details that will facilitate better preclinical drug/therapy design to target specific components involved in the disease pathogenesis. This review focuses on common animal models that are particularly useful for the study of UC and its therapeutic strategy. Recent reports of the latest compounds, therapeutic strategies, and approaches tested on UC animal models are also discussed.
Keywords: inflammatory bowel disease, preclinical trials, emerging therapy
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.